CMC

61.17

-0.88%↓

FUL

58

-4.27%↓

USAU

15.45

-2.4%↓

CMC

61.17

-0.88%↓

FUL

58

-4.27%↓

USAU

15.45

-2.4%↓

CMC

61.17

-0.88%↓

FUL

58

-4.27%↓

USAU

15.45

-2.4%↓

CMC

61.17

-0.88%↓

FUL

58

-4.27%↓

USAU

15.45

-2.4%↓

CMC

61.17

-0.88%↓

FUL

58

-4.27%↓

USAU

15.45

-2.4%↓

Search

Bioceres Crop Solutions Corp

Fermé

0.55 1.85

Résumé

Variation du prix de l'action

24h

Actuel

Min

0.52

Max

0.58

Chiffres clés

By Trading Economics

Revenu

5.7M

-1.8M

Ventes

-3.8M

74M

Marge bénéficiaire

-2.399

Employés

751

EBITDA

-2.4M

6.8M

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-1.7M

26M

Ouverture précédente

-1.3

Clôture précédente

0.55

Score Technique

By Trading Central

Confiance

Very Strong Bullish Evidence

Bioceres Crop Solutions Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

6 avr. 2026, 23:17 UTC

Résultats

Samsung Forecasts Record First-Quarter Operating Profit

6 avr. 2026, 23:00 UTC

Actions en Tendance

Stocks to Watch: Health Insurers, Mawson, Owlet

6 avr. 2026, 22:13 UTC

Principaux Mouvements du Marché

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 avr. 2026, 21:46 UTC

Acquisitions, Fusions, Rachats

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 avr. 2026, 17:09 UTC

Principaux Mouvements du Marché

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 avr. 2026, 16:56 UTC

Principaux Événements d'Actualité

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 avr. 2026, 14:47 UTC

Principaux Mouvements du Marché

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 avr. 2026, 00:00 UTC

Principaux Événements d'Actualité

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 avr. 2026, 23:58 UTC

Market Talk
Principaux Événements d'Actualité

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 avr. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 avr. 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 avr. 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 avr. 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6 avr. 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 avr. 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6 avr. 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6 avr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6 avr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 avr. 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 avr. 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 avr. 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 avr. 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 avr. 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6 avr. 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 avr. 2026, 18:36 UTC

Acquisitions, Fusions, Rachats

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 avr. 2026, 17:59 UTC

Market Talk
Principaux Événements d'Actualité

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 avr. 2026, 17:13 UTC

Acquisitions, Fusions, Rachats

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 avr. 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 avr. 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 avr. 2026, 14:59 UTC

Résultats

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Comparaison

Variation de prix

Bioceres Crop Solutions Corp prévision

Note du Consensus

By TipRanks

0 ratings

0

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

4.17 / 4.59Support & Résistance

Court Terme

Very Strong Bullish Evidence

Moyen Terme

Weak Bearish Evidence

Long Terme

Weak Bearish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Bioceres Crop Solutions Corp

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.
help-icon Live chat